Skip to main content
Watch Insiders
CRVS filings

Corporate insider profile

David Scott Moore Filing Activity

Latest reported as Director of Corvus Pharmaceuticals, Inc. (CRVS).

Purchase filings
1
Reported companies
1
Net open-market value
$250,236
Latest transaction
Jun 11, 2026

Affiliated corporations

Reported company relationships

CRVSLatest reported

Corvus Pharmaceuticals, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 11, 2026Corvus Pharmaceuticals, Inc. (CRVS)DirectorOpen Market Purchase21,700$11.53$250,236